In-Vitro Diagnostics, Point of Care Testing & Pathology Services

Supply Chain Coordination Limited is establishing a National Framework Agreement, identified as Project_1717, for the provision of In-Vitro Diagnostic Devices, Point of Care Testing products, and related pathology services across the United Kingdom. The scope is divided into three lots: Lot 1 focuses on end-to-end Pathology Managed Services to expand diagnostics into community settings; Lot 2 covers Pathology Software Solutions including AI platforms and middleware; and Lot 3 addresses Diagnostics Testing Solutions across various disciplines such as biochemistry, genomics, and haematology. The framework includes the supply of core laboratory equipment, consumables, reagent rental agreements, and specimen storage and collection services. The procurement is structured as an open framework with an overall intended duration of eight years, with the initial term running from October 18, 2027, to October 17, 2029. There is no limit on the number of suppliers who can be appointed. Award criteria vary by lot, with Lot 1 and 2 weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is weighted at 60 percent for quality, 30 percent for cost, and 10 percent for social value. The authority may award contracts through the framework either with or without further competition. Small and medium-sized enterprises, as well as voluntary, community and social enterprises, are eligible to participate. The deadline for tender submissions is December 16, 2026.